Colchester selectboard ratifies state settlement with opioid manufacturers and distributors

Posted

As part of a nationwide effort to hold the major perpetrators of the opioid crisis accountable, the Colchester selectboard has signed on to ratify settlements negotiated by the state’s attorney general with various opioid distributors who were sued by his officer last year.

At Colchester’s most recent November 9 meeting the board unanimously voted to ratify the settlements and to authorize Town Manager Aaron Frank to sign any documents or enter into any agreements to effectuate the settlements.

The settlement itself is part of a nationwide settlement agreement valued at $26 billion. Vermont’s portion is around $60 million.

At least 2,500 lawsuits with individual cities, towns, fire districts, hospitals, etc. within the U.S. were consolidated into one court proceeding in Ohio.

The settlement agreement will resolve the claims of both states and local governments across the country, including those in Vermont, according to a press release from the attorney general’s office.

In late October, Vermont’s Deputy Attorney General Josh Diamond, attended a Colchester Selectboard meeting to present the settlements and the town’s options.

“It doesn’t take far for us to look to see the scope of the harm that the opioid crisis has caused our state whether it be family members, good friends or neighbors. If it hasn’t touched you directly, it has probably touched someone very close to you directly,” Diamond said.

Diamond made clear that while the numbers his office were able to achieve are meaningful, no amount of money will be able to replace the lost loved ones or the harm done by this crisis.

The settlements themselves

There are two settlements proposed: one with the distributors (McKesson, Cardinal, and AmerisourceBergen) and one with the manufacturers (Johnson & Johnson and Janssen).

The case against the distributors alleges a violation of the Consumer Protection Act by distributing large quantities of addictive opioids into Vermont and failing to design controls that could prevent the fulfilment of suspicious orders that would create a risk of abuse.

They also allege the companies colluded in marketing efforts with the opioid manufacturers and failed to implement effective anti-diversion programs, according to a Sept. memo from the attorney general’s office.

The money and where it's going

The distributors have agreed nationally to pay $21 billion over 18 years, of which states and localities within the U.S. will see around $18.5 billion. Vermont’s portion of this settlement is around $53 million.

The manufacturers have agreed to pay $5 billion over 10 years. Around $4.264 billion will go to states and localities within the U.S. Vermont’s portion amounts to around $12 million.

Of the money Vermont is receiving, 15% will be going to the state’s general fund that must be used for remediation of the opioid crisis, 15% will go to Vermont’s localities and 70% will go into an abatement fund used also for remediating the opioid crisis, Diamond said at the Oct. meeting.

The bulk of the money in the abatement fund will be allocated by a yet-to-be-determined state agency, guided by an advisory committee that will be made of representatives from the towns and cities.

In order to maximize these settlement payments, the state needs every locality with over 10,000 people as well as the four jurisdictions that are suing (Brattleboro, Bennington, Sharon and Saint Albans) to sign off on the settlement, Diamond said.

Diamond said that besides the money, the settlement forces distributors to set up a system monitoring where opioids are going, giving agencies the ability to spot red flags. The settlement also bans manufacturers from selling and advertising opioids within the U.S.

What does this mean for Colchester?

The amount of money coming to the localities within the state including Colchester will be determined by population but also things like opioid deaths and the rate of opioid use disorder.

All money going to Colchester will have to be used for remediating the opioid crisis though there is a lot of room for potential uses, expanding to things like emergency services, recovery services, prevention programs and many others, Diamond said.

Whether or not the distributors sign onto the deal is dependent on how many states and localities have signed on, Diamond said. Currently, there are enough states for the distributors to sign off and on Jan. 2 they will assess whether or not there are enough localities that have signed on.

The distributors do have the option to walk away and it is possible this could fall through come that date, Diamond said. However, Diamond said that he is hopeful there will be a critical mass to get the settlement done.

#csnltop